Loss of parla Function Results in Inactivity, Olfactory Impairment, and Dopamine Neuron Loss in Zebrafish

The presenilin-associated rhomboid-like ( ) gene was found to contribute to mitochondrial morphology and function and was linked to familial Parkinson's disease (PD). The gene product is a mitochondrial intramembrane cleaving protease that acts on a number of mitochondrial proteins involved in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicines 2021-02, Vol.9 (2), p.205
Hauptverfasser: Merhi, Rawan, Kalyn, Michael, Zhu-Pawlowsky, Amanda, Ekker, Marc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The presenilin-associated rhomboid-like ( ) gene was found to contribute to mitochondrial morphology and function and was linked to familial Parkinson's disease (PD). The gene product is a mitochondrial intramembrane cleaving protease that acts on a number of mitochondrial proteins involved in mitochondrial morphology, apoptosis, and mitophagy. To date, functional and genetic studies of have been mainly performed in mammals. However, little is known about function and its role in dopaminergic (DA) neuron development in vertebrates. The zebrafish genome comprises two paralogs: and . Here, we established a loss-of-function mutation in via CRISPR/Cas9-mediated mutagenesis. We examined DA neuron numbers in the adult brain and expression of genes associated with DA neuron function in larvae and adults. We show that loss of function results in loss of DA neurons, mainly in the olfactory bulb. Changes in the levels of transcripts supported this neuronal loss. Expression of , a gene involved in mitochondrial fission, was increased in mutants. Finally, we showed that loss of function translates into impaired olfaction and altered locomotion parameters. These results suggest a role for in the development and/or maintenance of DA neuron function in zebrafish.
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines9020205